RapidAI is a medical imaging and clinical decision support platform powered by artificial intelligence, designed to assist in the diagnosis and treatment of cerebrovascular and vascular conditions. The platform is widely used for stroke imaging and is recognized for helping hospitals improve diagnostic speed, accuracy, and workflow coordination during critical emergencies like ischemic stroke, hemorrhagic stroke, and pulmonary embolism.
Developed from research originally conducted at Stanford University, RapidAI has grown into a globally trusted platform used in over 2,000 hospitals across more than 100 countries. It plays a pivotal role in time-sensitive diagnoses, helping clinical teams identify treatment paths faster and more confidently.
Features
RapidAI offers a suite of AI-powered modules that support multiple neurovascular and vascular conditions. Key products include:
Rapid ASPECTS helps physicians assess early signs of ischemic stroke by automatically scoring non-contrast CT scans. It reduces inter-reader variability and supports faster diagnosis in acute stroke cases.
Rapid CTA analyzes CT angiography scans to identify large vessel occlusions and assess collateral blood flow. It provides color-coded maps and vessel density analysis to aid clinicians in selecting patients for endovascular therapy.
Rapid CTP processes CT perfusion imaging to determine infarct core and salvageable brain tissue. It helps assess patient eligibility for thrombectomy and guide clinical decisions beyond standard time windows.
Rapid ICH automatically detects and quantifies intracerebral hemorrhages on non-contrast CT scans. It provides volume measurements and visual maps, streamlining diagnosis of hemorrhagic stroke.
Rapid PE analyzes CT pulmonary angiography scans to assess pulmonary embolism severity and right heart strain, providing RV/LV ratios and clot burden scores to guide care.
Rapid Mobile enables real-time communication and image sharing among stroke teams. Clinicians can access RapidAI results on smartphones or tablets, improving coordination between emergency departments, neurologists, and intervention teams.
All tools are FDA cleared and CE marked, supporting global compliance. RapidAI also integrates with PACS, RIS, and hospital workflows, ensuring smooth adoption and minimal disruption to existing systems.
How It Works
RapidAI works by integrating directly into a hospital’s radiology and emergency care systems. When a patient arrives with stroke symptoms, a CT or MRI scan is performed and automatically routed through the RapidAI platform.
Using advanced AI algorithms, the platform analyzes the scan in under two minutes and generates a visual report with quantitative data. This includes maps of brain perfusion, hemorrhage volumes, occlusion sites, and more. The data is then made available instantly on the Rapid Mobile app and desktop interfaces.
The platform supports early diagnosis and triage decisions by flagging critical findings and providing standardized measurements that align with international guidelines. It enables both onsite and remote physicians to collaborate on treatment plans with access to the same real-time data.
Use Cases
One of the main use cases of RapidAI is in stroke centers and emergency departments, where every minute counts. The platform allows clinicians to detect ischemic or hemorrhagic stroke within minutes and determine if a patient qualifies for thrombolysis or mechanical thrombectomy.
RapidAI is used by telestroke networks to evaluate imaging remotely, allowing specialists to provide consultations in hospitals that do not have in-house neurologists. The mobile platform ensures that all team members—from EMS to neurosurgeons—are informed instantly when a new case is activated.
In pulmonary embolism care, Rapid PE helps detect life-threatening clots early and evaluate their severity, allowing care teams to make faster, more accurate decisions in acute settings.
The platform also supports clinical research by offering de-identified data collection and analytics features, helping institutions improve protocols and publish outcomes-based studies.
Pricing
RapidAI does not list specific pricing on its website. The platform operates under an enterprise software model with pricing based on factors such as the number of modules deployed, imaging volume, hospital size, and integration requirements.
Hospitals and healthcare systems interested in RapidAI’s solutions are encouraged to contact the sales team through the official website to request a tailored quote and product demonstration.
Strengths
A key strength of RapidAI is its specialization in time-sensitive conditions, especially stroke, where fast and accurate decision-making is critical. The platform’s ability to process scans in under two minutes significantly reduces door-to-needle time and improves patient outcomes.
Its FDA clearance and CE mark demonstrate strong clinical validation and compliance with international medical device regulations. The wide adoption across thousands of hospitals reflects its trustworthiness and proven effectiveness.
RapidAI’s mobile accessibility enhances care team coordination, while the range of supported imaging modalities—from CT to MRI—ensures flexibility across hospital infrastructure. Its robust cloud-based and on-premises deployment options suit both large health systems and smaller community hospitals.
Drawbacks
One potential drawback is the enterprise nature of the product, which may be less accessible to small clinics or low-resource settings without the required infrastructure. The need for advanced imaging equipment like CT perfusion or CTA also limits its use in facilities that lack these modalities.
Another limitation is the absence of publicly available pricing and technical details, which may make initial evaluation and comparison difficult for prospective buyers. As with any AI system, clinicians must remain vigilant and not rely solely on automated outputs for final decisions.
Integration with existing systems can also require technical support and may involve initial setup costs or IT coordination, which could slow deployment in some healthcare environments.
Comparison with Other Tools
Compared to competitors like Viz.ai, Aidoc, or Brainomix, RapidAI is recognized for its comprehensive stroke care suite and its origins in academic research. Viz.ai also offers stroke imaging AI but emphasizes its workflow notification system. Aidoc provides a broader AI imaging portfolio across multiple body systems, while RapidAI maintains a tight focus on neurovascular and vascular care.
Brainomix is another strong competitor in stroke imaging, especially in Europe, but RapidAI’s range of modules and FDA/CE approvals give it a broader global reach. Additionally, RapidAI’s mobile platform and deep integration with telestroke workflows make it particularly suited for distributed care models.
Customer Reviews and Testimonials
RapidAI is widely endorsed by leading stroke centers and health systems globally. Many institutions have reported significant reductions in treatment delays and improved patient outcomes after implementing the platform.
According to case studies published on the official website, hospitals using RapidAI have seen improved coordination between care teams and better identification of thrombectomy-eligible patients. Clinicians frequently highlight the platform’s speed, reliability, and ease of use.
RapidAI has received recognition in academic journals, conference presentations, and news features related to stroke care innovation. Its adoption by prominent networks like the Mount Sinai Health System and Mercy Health reflects strong user confidence and satisfaction.
Conclusion
RapidAI is a powerful AI-driven platform that transforms acute care through advanced imaging analysis and real-time clinical decision support. Focused on stroke and vascular conditions, it empowers healthcare teams to act faster, make more informed decisions, and ultimately improve patient outcomes.
With tools like Rapid ASPECTS, Rapid CTA, and Rapid PE, the platform covers a wide range of diagnostic needs and supports clinicians from the emergency room to the intervention suite. Its real-world clinical validation, widespread hospital use, and mobile accessibility make it one of the most trusted solutions in AI-powered radiology today.
For hospitals seeking to modernize their stroke care or vascular diagnostics with proven AI tools, RapidAI offers a robust, scalable, and reliable option. To learn more or request a demo, visit the official RapidAI website at https://www.rapidai.com.
